Quick Takeaways
- Michael Egholm has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $13,026,041.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Michael Egholm
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Michael Egholm is at least $13,026,041 dollars as of 08 Apr 2026. Michael Egholm is the President & CEO, Director of STANDARD BIOTOOLS INC. and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $13.03M.
- Signature
- /s/ Michael Egholm by Hanjoon Alex Kim, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Michael Egholm and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: STANDARD BIOTOOLS INC. ($13,026,041).
- Past-year value change for that position: -$15,137.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Michael Egholm
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | President & CEO, Director | $13,026,041 | -$15,137 | -0.12% | 20 Mar 2026 |
| ISO | IsoPlexis Corp | Director | 16 Jun 2022 |
Insider Transactions Reported by Michael Egholm:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.